Topical and peripheral ketamine as an analgesic

Anesthesia and Analgesia

Volumn 119, Issue 1, 2014, Pages 170-178

  Sawynok, Jana ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; BACLOFEN; CAPSAICIN; CARBAMAZEPINE; CLONIDINE; DIMETHYL SULFOXIDE; GABAPENTIN; KETAMINE; KETOPROFEN; LIDOCAINE; PALMIDROL;

ANALGESIA; ANTIINFLAMMATORY ACTIVITY; COMPLEX REGIONAL PAIN SYNDROME; DIABETIC NEUROPATHY; DRUG EFFICACY; DRUG MECHANISM; ERYTHROMELALGIA; GENITAL PAIN; HUMAN; HYPERALGESIA; LOW DRUG DOSE; MOUTH PAIN; NERVE COMPRESSION; NEUROPATHIC PAIN; NONHUMAN; PAIN; PERCEPTIVE THRESHOLD; PERINEAL PAIN; PERIPHERAL NEUROPATHY; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; PROCTODYNIA; RADICULOPATHY; RECTAL PAIN; REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADMINISTRATION, TOPICAL; ANALGESICS; CLINICAL TRIALS AS TOPIC; DRUG THERAPY, COMBINATION; HUMANS; KETAMINE; NEURALGIA; PAIN, POSTOPERATIVE;

EID: 84903206237     PISSN: 00032999     EISSN: 15267598     Source Type: Journal    
DOI: 10.1213/ANE.0000000000000246     Document Type: Review

References (105)

1. White PF, Way WL, Trevor AJ. Ketamine-its pharmacology and therapeutic uses. Anesthesiology 1982;56:119-36
2. Reich DL, Silvay G. Ketamine: an update on the frst twenty-fve years of clinical experience. Can J Anaesth 1989;36:186-97 (Pubitemid 19110402)
3. Lodge D. The history of the pharmacology and cloning of iono-tropic glutamate receptors and the development of idiosyncratic nomenclature. Neuropharmacology 2009;56:6-21
4. Coderre TJ, Katz J, Vaccarino AL, Melzack R. Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain 1993;52:259-85 (Pubitemid 23080546)
5. Fisher K, Coderre TJ, Hagen NA. Targeting the N-methyl-D-aspartate receptor for chronic pain management. Preclinical animal studies, recent clinical experience and future research directions. J Pain Symptom Manage 2000;20:358-73
6. Hocking G, Cousins MJ. Ketamine in chronic pain management: an evidence-based review. Anesth Analg 2003;97:1730-9 (Pubitemid 37475130)
7. Bell RF. Ketamine for chronic non-cancer pain. Pain 2009;141:210-4
8. Blonk MI, Koder BG, van den Bemt PM, Huygen FJ. Use of oral ketamine in chronic pain management: a review. Eur J Pain 2010;14:466-72
9. Noppers I, Niesters M, Aarts L, Smith T, Sarton E, Dahan A. Ketamine for the treatment of chronic non-cancer pain. Expert Opin Pharmacother 2010;11:2417-29
10. Chizh BA, Headley PM. NMDA antagonists and neuropathic pain-multiple drug targets and multiple uses. Curr Pharm Des 2005;11:2977-94 (Pubitemid 41158087)
11. Chizh BA. Low dose ketamine: a therapeutic and research tool to explore N-methyl-D-aspartate (NMDA) receptor-mediated plasticity in pain pathways. J Psychopharmacol 2007;21:259-71 (Pubitemid 46938541)
12. Koller M, Urwyler S. Novel N-methyl-D-aspartate receptor antagonists: a review of compounds patented since 2006. Expert Opin Ther Pat 2010;20:1683-702
13. Santangelo RM, Acker TM, Zimmerman SS, Katzman BM, Strong KL, Traynelis SF, Liotta DC. Novel NMDA receptor modulators: an update. Expert Opin Ther Pat 2012;22:1337-52
14. Carlton SM. Peripheral excitatory amino acids. Curr Opin Pharmacol 2001;1:52-6 (Pubitemid 33585957)
15. Miller KE, Hoffman EM, Sutharshan M, Schechter R. Glutamate pharmacology and metabolism in peripheral primary afferents: physiological and pathophysiological mechanisms. Pharmacol Ther 2011;130:283-309
16. Crowley KL, Flores JA, Hughes CN, Iacono R P. Clinical application of ketamine ointment in the treatment of sympathetically maintained pain. Int J Pharm Compd 1998;2:122-7
17. Gammaitoni A, Gallagher RM, Welz-Bosna M. Topical ket-amine gel: possible role in treating neuropathic pain. Pain Med 2000;1:97-100
18. Sawynok J. Topical and peripherally acting analgesics. Pharmacol Rev 2003;55:1-20 (Pubitemid 36268396)
19. Cairns BE. Peripheral Receptor Targets for Analgesia: Novel Approaches to Pain Management. Hoboken, NJ: John Wiley & Sons, Inc., 2009
20. Eide PK, Stubhaug A, Breivik H, Oye I. Reply to S.T. Meller: Ketamine: relief from chronic pain through actions at the NMDA receptor. Pain 1997;72:289-91
21. Hirota K, Lambert DG. Ketamine: its mechanism(s) of action and unusual clinical uses. Br J Anaesth 1996;77:441-4 (Pubitemid 26341027)
22. Meller ST. Ketamine: relief from chronic pain through actions at the NMDA receptor? Pain 1996;68:435-6 (Pubitemid 27025904)
23. Kohrs R, Durieux ME. Ketamine: teaching an old drug new tricks. Anesth Analg 1998;87:1186-93 (Pubitemid 28501183)
24. Smith DJ, Bouchal RL, deSanctis CA, Monroe PJ, Amedro JB, Perrotti JM, Crisp T. Properties of the interaction between ketamine and opiate binding sites in vivo and in vitro. Neuropharmacology 1987;26:1253-60 (Pubitemid 17154877)
25. Nishimura M, Sato K, Okada T, Yoshiya I, Schloss P, Shimada S, Tohyama M. Ketamine inhibits monoamine transporters expressed in human embryonic kidney 293 cells. Anesthesiology 1998;88:768-74 (Pubitemid 28120212)
26. Kapur S, Seeman P. NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D(2) and serotonin 5-HT(2)receptors-implications for models of schizophrenia. Mol Psychiatry 2002;7:837-44
27. Schnoebel R, Wolff M, Peters SC, Bräu ME, Scholz A, Hempelmann G, Olschewski H, Olschewski A. Ketamine impairs excitability in superfcial dorsal horn neurones by blocking sodium and voltage-gated potassium currents. Br J Pharmacol 2005;146:826-33 (Pubitemid 41622249)
28. Hayashi Y, Kawaji K, Sun L, Zhang X, Koyano K, Yokoyama T, Kohsaka S, Inoue K, Nakanishi H. Microglial Ca(2+)-activated K(+) channels are possible molecular targets for the analgesic effects of S-ketamine on neuropathic pain. J Neurosci 2011;31:17370-82
29. Siddiqui AS, Raees US, Siddiqui SZ, Raza SA. Effcacy of pre-incisional peritonsillar infltration of ketamine for post-ton-sillectomy analgesia in children. J Coll Physicians Surg Pak 2013;23:533-7
30. Ugur KS, Karabayirli S, Demircioglu Rl, Ark N, Kurtaran H, Muslu B, Sert H. The comparison of preincisional peritonsillar infltration of ketamine and tramadol for postoperative pain relief on children following adenotonsillectomy Int J Pediatr Otorhinolaryngol 2013;77:1825-9
31. Romero TR, Galdino GS, Silva GC, Resende LC, Perez AC, Côrtes SF, Duarte ID. Ketamine activates the L-arginine/nitric oxide/cyclic guanosine monophosphate pathway to induce peripheral antinociception in rats. Anesth Analg 2011;113:1254-9
32. Romero TR, Duarte ID. Involvement of ATP-sensitive K(+) channels in the peripheral antinociceptive effect induced by ketamine. Vet Anaesth Analg 2013;40:419-24
33. Zhao P, Barr TP, Hou Q, Dib-Hajj SD, Black JA, Albrecht PJ, Petersen K, Eisenberg E, Wymer JP, Rice FL, Waxman SG Voltage-gated sodium channel expression in rat and human epidermal keratinocytes: evidence for a role in pain. Pain 2008;139:90-105
34. Radtke C, Vogt PM, Devor M, Kocsis JD. Keratinocytes acting on injured afferents induce extreme neuronal hyperexcitability and chronic pain. Pain 2010;148:94-102
35. Hou Q, Barr T, Gee L, Vickers J, Wymer J, Borsani E, Rodella L, Getsios S, Burdo T, Eisenberg E, Guha U, Lavker R, Kessler J, Chittur S, Fiorino D, Rice F, Albrecht P. Keratinocyte expression of calcitonin gene-related peptide p: implications for neuropathic and infammatory pain mechanisms. Pain 2011;152:2036-51
36. Genever PG, Maxfeld SJ, Kennovin GD, Maltman J, Bowgen CJ, Raxworthy MJ, Skerry TM. Evidence for a novel glutamate-mediated signaling pathway in keratinocytes. J Invest Dermatol 1999;112:337-42 (Pubitemid 29125111)
37. Fischer M, Glanz D, William T, Klapperstück T, Wohlrab J, Marsch WCh N-methyl-D-aspartate receptors infuence the intracellular calcium concentration of keratinocytes. Exp Dermatol 2004;13:512-9 (Pubitemid 39144552)
38. Nahm WK, Philpot BD, Adams MM, Badiavas EV, Zhou LH, Butmarc J, Bear MF, Falanga V. Signifcance of N-methyl-D-aspartate (NMDA) receptor-mediated signaling in human keratinocytes. J Cell Physiol 2004;200:309-17 (Pubitemid 38880214)
39. Fischer M, Glanz D, Urbatzka M, Brzoska T, Abels C. Keratinocytes: a source of the transmitter L-glutamate in the epidermis. Exp Dermatol 2009; 18: 1064-6
40. Liu FL, Chen TL, Chen RM. Mechanisms of ketamine-induced immunosuppression. Acta Anaesthesiol Taiwan 2012;50:172-7
41. De Kock M, Loix S, Lavand'homme P. Ketamine and peripheral infammation. CNS Neurosci Ther 2013;19:403-10
42. Dale O, Somogyi AA, Li Y, Sullivan T, Shavit Y Does intraoperative ketamine attenuate infammatory reactivity following surgery? A systematic review and meta-analysis. Anesth Analg 2012;115:934-43
43. Hudetz JA, Iqbal Z, Gandhi SD, Patterson KM, Byrne AJ, Hudetz AG, Pagel PS, Warltier DC. Ketamine attenuates postoperative cognitive dysfunction after cardiac surgery. Acta Anaesthesiol Scand 2009;53:864-72
44. Zhu MM, Zhou QH, Zhu MH, Rong HB, Xu YM, Qian YN, Fu CZ. Effects of nebulized ketamine on allergen-induced airway hyperresponsiveness and infammation in actively sensitized Brown-Norway rats. J Infamm (Lond) 2007;4:10
45. Bruehl S. An update on the pathophysiology of complex regional pain syndrome. Anesthesiology 2010;113:713-25
46. Coderre TJ, Bennett GJ. A hypothesis for the cause of complex regional pain syndrome-type I (refex sympathetic dystrophy): pain due to deep-tissue microvascular pathology. Pain Med 2010;11:1224-38
47. Carlton SM, Hargett GL, Coggeshall RE. Localization and activation of glutamate receptors in unmyelinated axons of rat glabrous skin. Neurosci Lett 1995;197:25-8
48. Zhou S, Bonasera L, Carlton SM. Peripheral administration of NMDA, AMPA or KA results in pain behaviors in rats. Neuroreport 1996;7:895-900 (Pubitemid 26167972)
49. Davidson EM, Coggeshall RE, Carlton SM. Peripheral NMDA and non-NMDA glutamate receptors contribute to nociceptive behaviors in the rat formalin test. Neuroreport 1997;8:941-6 (Pubitemid 27152151)
50. Davidson EM, Carlton SM. Intraplantar injection of dextror-phan, ketamine or memantine attenuates formalin-induced behaviors. Brain Res 1998;785:136-42 (Pubitemid 28194763)
51. Oatway M, Reid A, Sawynok J. Peripheral antihyperalgesic and analgesic actions of ketamine and amitriptyline in a model of mild thermal injury in the rat. Anesth Analg 2003;97:168-73 (Pubitemid 36736556)
52. Warncke T, Jørum E, Stubhaug A. Local treatment with the N-methyl-D-aspartate receptor antagonist ketamine, inhibits development of secondary hyperalgesia in man by a peripheral action. Neurosci Lett 1997;227:1-4 (Pubitemid 27239525)
53. Pedersen JL, Galle TS, Kehlet H. Peripheral analgesic effects of ketamine in acute infammatory pain. Anesthesiology 1998;89:58-66 (Pubitemid 28319567)
54. Koppert W, Zeck S, Blunk JA, Schmelz M, Likar R, Sittl R. The effects of intradermal fentanyl and ketamine on capsaicin-induced secondary hyperalgesia and fare reaction. Anesth Analg 1999;89:1521-7
55. Gottrup H, Bach FW, Arendt-Nielsen L, Jensen TS. Peripheral lidocaine but not ketamine inhibits capsaicin-induced hyperalgesia in humans. Br J Anaesth 2000;85:520-8
56. Gottrup H, Bach FW, Jensen TS. Differential effects of peripheral ketamine and lidocaine on skin fux and hyperalgesia induced by intradermal capsaicin in humans. Clin Physiol Funct Imaging 2004;24:103-8 (Pubitemid 38489328)
57. Tverskoy M, Oren M, Vaskovich M, Dashkovsky I, Kissin I. Ketamine enhances local anesthetic and analgesic effects of bupivacaine by peripheral mechanism: a study in postoperative patients. Neurosci Lett 1996;215:5-8 (Pubitemid 26290499)
58. Pöyhiä R, Vainio A. Topically administered ketamine reduces capsaicin-evoked mechanical hyperalgesia. Clin J Pain 2006;22:32-6 (Pubitemid 44378560)
59. Finch PM, Knudsen L, Drummond PD. Reduction of allo-dynia in patients with complex regional pain syndrome: A double-blind placebo-controlled trial of topical ketamine. Pain 2009;146:18-25
60. Grant IS, Nimmo WS, Clements JA. Pharmacokinetics and analgesic effects of i.m. and oral ketamine. Br J Anaesth 1981;53:805-10 (Pubitemid 11044337)
61. Clements JA, Nimmo WS, Grant IS. Bioavailability, pharmacokinetics, and analgesic activity of ketamine in humans. J Pharm Sci 1982;71:539-42 (Pubitemid 12063731)
62. Leung A, Wallace MS, Ridgeway B, Yaksh T. Concentration-effect relationship of intravenous alfentanil and ketamine on peripheral neurosensory thresholds, allodynia and hyperalgesia of neuropathic pain. Pain 2001;91:177-87 (Pubitemid 32279619)
63. Wallace MS, Ridgeway B 3rd, Leung A, Schulteis G, Yaksh TL. Concentration-effect relationships for intravenous alfentanil and ketamine infusions in human volunteers: effects on acute thresholds and capsaicin-evoked hyperpathia. J Clin Pharmacol 2002;42:70-80 (Pubitemid 34041041)
64. Baron R, Binder A, Wasner G. Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol 2010;9:807-19
65. von Hehn CA, Baron R, Woolf CJ. Deconstructing the neuropathic pain phenotype to reveal neural mechanisms. Neuron 2012;73:638-52
66. Attal N, Cruccu G, Baron R, Haanpää M, Hansson P, Jensen TS, Nurmikko T; European Federation of Neurological Societies. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. Eur J Neurol 2010;17:1113-e88
67. Dworkin RH, O'Connor AB, Audette J, Baron R, Gourlay GK, Haanpää ML, Kent JL, Krane EJ, Lebel AA, Levy RM, Mackey SC, Mayer J, Miaskowski C, Raja SN, Rice AS, Schmader KE, Stacey B, Stanos S, Treede RD, Turk DC, Walco GA, Wells CD. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc 2010;85:S3-14
68. Mick G, Correa-Illanes G Topical pain management with the 5% lidocaine medicated plaster-a review. Curr Med Res Opin 2012;28:937-51
69. Haanpää M, Treede RD. Capsaicin for neuropathic pain: linking traditional medicine and molecular biology. Eur Neurol 2012;68:264-75
70. Ushida T, Tani T, Kanbara T, Zinchuk VS, Kawasaki M, Yamamoto H. Analgesic effects of ketamine ointment in patients with complex regional pain syndrome type 1. Reg Anesth Pain Med 2002;27:524-8
71. Quan D, Wellish M, Gilden DH. Topical ketamine treatment of postherpetic neuralgia. Neurology 2003;60:1391-2 (Pubitemid 36461006)
72. Keppel Hesselink JM, Kopsky DJ. Intractable neuropathic pain due to ulnar nerve entrapment treated with cannabis and ketamine 10%. J Clin Anesth 2012;24:78-9
73. Lynch ME, Clark AJ, Sawynok J. A pilot study examining topical amitriptyline, ketamine, and a combination of both in the treatment of neuropathic pain. Clin J Pain 2003;19:323-8 (Pubitemid 37075674)
74. Barros GA, Miot HA, Braz AM, Ramos F, Borges MA. Topical (S)-ketamine for pain management of postherpetic neuralgia. An Bras Dermatol 2012;87:504-5
75. Lynch ME, Clark AJ, Sawynok J, Sullivan MJ. Topical 2% amitriptyline and 1% ketamine in neuropathic pain syndromes: a randomized, double-blind, placebo-controlled trial. Anesthesiology 2005;103:140-6 (Pubitemid 40943146)
76. Mahoney JM, Vardaxis V, Moore JL, Hall AM, Haffner KE, Peterson MC. Topical ketamine cream in the treatment of painful diabetic neuropathy: a randomized, placebo-controlled, double-blind initial study. J Am Podiatr Med Assoc 2012;102:178-83
77. Lynch ME, Clark AJ, Sawynok J, Sullivan MJ. Topical amitriptyline and ketamine in neuropathic pain syndromes: an open-label study. J Pain 2005;6:644-9 (Pubitemid 41395055)
78. Lockhart E. Topical combination of amitriptyline and ketamine for post herpetic neuralgia. J Pain 2004;5:S82
79. Everton D, Bhagwat D, Damask M: A multicenter, double-blind, randomized, placebo controlled study of the effcacy/safety of two doses of amitriptyline/ketamine topical cream in treating post-herpetic neuralgia (PHN). J Pain 2007;8:S47
80. Barton DL, Wos EJ, Qin R, Mattar BI, Green NB, Lanier KS, Bearden JD 3rd, Kugler JW, Hoff KL, Reddy PS, Rowland KM Jr, Riepl M, Christensen B, Loprinzi CL. A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA. Support Care Cancer 2011;19:833-41
81. Uzaraga I, Gerbis B, Holwerda E, Gillis D, Wai E. Topical amitriptyline, ketamine, and lidocaine in neuropathic pain caused by radiation skin reaction: a pilot study. Support Care Cancer 2012;20:1515-24
82. Sandroni P, Davis MD. Combination gel of 1% amitriptyline and 0.5% ketamine to treat refractory erythromelalgia pain: a new treatment option? Arch Dermatol 2006;142:283-6
83. Poterucha TJ, Weiss WT, Warndahl RA, Rho RH, Sandroni P, Davis MD, Murphy SL. Topical amitriptyline combined with ketamine for the treatment of erythromelalgia: a retrospective study of 36 patients at Mayo Clinic. J Drugs Dermatol 2013;12:308-10
84. Lehman JS, Sciallis GF. Effective use of topical amitriptyline hydrochloride 2.5% and ketamine hydrochloride 0.5% for analgesia in refractory proctodynia. J Drugs Dermatol 2008;7:887-9
85. Poterucha TJ, Murphy SL, Rho RH, Sandroni P, Warndahl RA, Weiss WT, Davis MD. Topical amitriptyline-ketamine for treatment of rectal, genital, and perineal pain and discomfort. Pain Physician 2012;15:485-8
86. Poterucha TJ, Murphy SL, Davis MD, Sandroni P, Rho RH, Warndahl RA, Weiss WT. Topical amitriptyline-ketamine for the treatment of brachioradial pruritus. JAMA Dermatol 2013;149:148-50
87. Poterucha TJ, Murphy SL, Sandroni P, Rho RH, Warndahl RA, Weiss WT, Davis MD. Topical amitriptyline combined with topical ketamine for the management of recalcitrant localized pruritus: a retrospective pilot study. J Am Acad Dermatol 2013;69:320-1
88. Kopsky DJ, Keppel Hesselink JM. Multimodal stepped care approach involving topical analgesics for severe intractable neuropathic pain in CRPS type 1: a case report. Case Rep Med 2011;2011:319750
89. Keppel Hesselink JM, Kopsky DJ. Treatment of chronic regional pain syndrome type 1 with palmitoylethanolamide and topical ketamine cream: modulation of nonneuronal cells. J Pain Res 2013;6:239-45
90. Zur E. Topical treatment of neuropathic pain using compounded medications. Clin J Pain 2014;30:73-91
91. Heir G, Karolchek S, Kalladka M, Vishwanath A, Gomes J, Khatri R, Nasri C, Eliav E, Ananthan S. Use of topical medication in orofacial neuropathic pain: a retrospective study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;105:466-9
92. Tam E, Furlan AD. Transdermal lidocaine and ketamine for neuropathic pain: a study of effectiveness and tolerability. Open Neurol J 2012;6:58-64
93. Baron R, Mayoral V, Leijon G, Binder A, Steigerwald I, Serpell M. 5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT study. Curr Med Res Opin 2009;25:1663-76
94. Binder A, Bruxelle J, Rogers P, Hans G, Bösl I, Baron R. Topical 5% lidocaine (lignocaine) medicated plaster treatment for post-herpetic neuralgia: results of a double-blind, placebo-controlled, multinational effcacy and safety trial. Clin Drug Investig 2009;29:393-408
95. Sawynok J. Topical analgesics for neuropathic pain: Preclinical exploration, clinical validation, future development. Eur J Pain 2014;18:465-81
96. Mankovsky T, Lynch M, Clark A, Sawynok J, Sullivan MJ. Pain catastrophizing predicts poor response to topical analgesics in patients with neuropathic pain. Pain Res Manag 2012;17:10-4
97. Slatkin NE, Rhiner M. Topical ketamine in the treatment of mucositis pain. Pain Med 2003;4:298-303
98. Canbay O, Celebi N, Sahin A, Celiker V, Ozgen S, Aypar U. Ketamine gargle for attenuating postoperative sore throat. Br J Anaesth 2008;100:490-3 (Pubitemid 351773616)
99. Rudra A, Ray S, Chatterjee S, Ahmed A, Ghosh S. Gargling with ketamine attenuates the postoperative sore throat. Indian J Anaesth 2009;53:40-3
100. Chan L, Lee ML, Lo YL. Postoperative sore throat and ket-amine gargle. Br J Anaesth 2010;105:97
101. Shrestha SK, Bhattarai B, Singh J. Ketamine gargling and postoperative sore throat. JNMA J Nepal Med Assoc 2010;50:282-5
102. Canbay O, Celebi N, Uzun S, Sahin A, Celiker V, Aypar U. Topical ketamine and morphine for post-tonsillectomy pain. Eur J Anaesthesiol 2008;25:287-92 (Pubitemid 351365306)
103. Tekelioglu UY, Apuhan T, Akkaya A, Demirhan A, Yildiz I, Simsek T, Gok U, Kocoglu H. Comparison of topical tramadol and ketamine in pain treatment after tonsillectomy. Paediatr Anaesth 2013;23:496-501
104. Dal D, Celebi N, Elvan EG, Celiker V, Aypar U. The effcacy of intravenous or peritonsillar infltration of ketamine for postoperative pain relief in children following adenotonsillectomy. Paediatr Anaesth 2007;17:263-9 (Pubitemid 46181389)
105. Honarmand A, Safavi MR, Jamshidi M. The preventative analgesic effect of preincisional peritonsillar infltration of two low doses of ketamine for postoperative pain relief in children following adenotonsillectomy. A randomized, double-blind, placebo-controlled study. Paediatr Anaesth 2008;18:508-14 (Pubitemid 351600177)